NYSE · DVAHealthcareHealth Services

DaVita Inc. (DVA)

$192.50−0.08%
Close Nov 5, 2026 · split-adjusted
Nov 4, 2026$192.66▲ 60.59% in range
Nov 4, 2025Low $103.87 · High $240.96Nov 4, 2026
What changed · written from our data
As of Nov 5, 2026

DaVita closed at $192.50 on Nov 5, down 0.08%, 20.1% below its 52-week closing high. Volume of 205.3K shares was 0.24× its 20-day average (below normal).

Split-adjusted performance: +8.9% over one month, -1.9% over six months, +60.5% over one year.

In the quarter ended Sep 30, 2026, revenue was $3.41B, up 3.3% from a year earlier, with a net margin of 6.5%.

Short interest was 4.9M shares at the Oct 15 settlement, down 4.7% from the prior report (7.9% of float, 9.7 days to cover).

Market cap$12.11B62.9M shares
Revenue · quarter$3.41B+3.3% YoY
Diluted EPS$3.40+66.7% YoY
P/E · TTM13.2×P/S 0.9×
Net margin6.5%Gross 28.1%
Dividend yieldNone
52-week range103.87 – 240.96−20.1% from high
Volume205.3K0.24× 20-day avg
Volatility · 60d35.3%Annualised
Short % of float7.9%9.7 days to cover
Net cash-$10.20BCash $566.3M
Next earnings—Not scheduled
Split-adjusted performance
1W −0.4%1M +8.9%3M +4.8%6M −1.9%YTD +69.4%1Y +60.5%3Y +149.3%5Y +68.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Health Services

Percentile among 20 companies (100 = best)

6-month momentum32
Revenue growth29
Net margin72
Value (low P/E)100
Size100

Industry medians: 6-month return +10.3%, revenue growth +7.2%, net margin 3.0%, P/E 72.2×.

Short interest

Details →
Shares short4.9M−4.7% vs prior
Days to cover9.7Settled Oct 15
% of float7.9%
Short vol. 10d77.8%of daily volume

Closest peers by size in Health Services

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
DVADaVita$192.50−0.08%−1.9%+3.3%6.5%13.2$12.11B
LFSTLifeStance Health Group$14.20−0.07%+60.5%+26.1%5.4%106.7$5.40BCompare
SHCSotera Health$15.98−2.50%+2.0%+4.4%18.0%26.3$4.56BCompare
PRVAPrivia Health Group$23.09+3.08%−3.8%+21.4%1.4%104.9$2.95BCompare
PGNYProgyny$34.23+13.72%+78.7%+5.3%8.0%33.4$2.63BCompare
WGSGeneDx Holdings$62.70−9.57%+54.8%+11.4%−15.5%—$1.87BCompare
AGLagilon health$107.44+11.65%+77.1%+5.9%2.3%—$1.80BCompare
USPHUS Physical Therapy$98.57+10.53%+67.1%+8.5%1.8%553.2$1.47BCompare
PNTGThe Pennant Group$36.57−16.97%+2.3%+35.8%3.0%39.5$1.28BCompare

Quick answers

What does DaVita do?
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually.
What is DVA's market cap?
$12.11B, based on the Nov 5 close of $192.50.
What is DVA's P/E ratio?
13.2× trailing-twelve-month earnings of $920.08M.
Does DaVita pay a dividend?
No regular cash dividend has been paid in the last year.
How much of DVA is sold short?
4.9M shares, 7.9% of float, as of Oct 15, 2026.
What sector is DVA in?
Healthcare, in the Health Services industry.

About DaVita

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

HQ: Denver, CO78,000 employeesListed Oct 31, 1995davita.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology